You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Details for Patent: 8,114,863

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,114,863 protect, and when does it expire?

Patent 8,114,863 protects ELUCIREM and is included in one NDA.

This patent has twenty-nine patent family members in thirteen countries.

Summary for Patent: 8,114,863

Title:	Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
Abstract:	The present invention relates to a compound of formula (II) chosen from (IIa) and (IIb) or of formula (VI) chosen from (VIa) and (VIb) of following general formulae:
Inventor(s):	Port Marc
Assignee:	Guerbet
Application Number:	US12083092
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 8,114,863

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-001	Sep 21, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-002	Sep 21, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-003	Sep 21, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-004	Sep 21, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-005	Sep 21, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
Guerbet	ELUCIREM	gadopiclenol	SOLUTION;INTRAVENOUS	216986-006	Sep 21, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,114,863

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1931673	⤷ Sign Up	301259	Netherlands	⤷ Sign Up
Brazil	PI0617151	⤷ Sign Up
Canada	2625196	⤷ Sign Up
Canada	2625207	⤷ Sign Up
China	101305006	⤷ Sign Up
China	103224495	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.